Science Explorer Interactive view Map
Researcher · AstraZeneca (United States) · United States

Mark Cobbold

Mark Cobbold publishes mostly in Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and Monoclonal and Polyclonal Antibodies Research.

ORCID 0000-0001-8931-4142 OpenAlex
World rank
#467,285
of 1,633,909 ranked researchers
Rank in United States
#158,500
of 358,040
Works
22
Citations
78
Citations per work
3.5

What does Mark Cobbold research?

Oncology: 34.5%Immunology: 24.1%Radiology, Nuclear Medicine and Imaging: 13.8%Molecular Biology: 6.9%other fields: 20.7%34%top field
Oncology34.5%Immunology24.1%Radiology, Nuclear Medicine and Imaging13.8%Molecular Biology6.9%other fields20.7%

Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.

  1. 1Oncology34% of their works
  2. 2Immunology24% of their works
  3. 3Radiology, Nuclear Medicine and Imaging14% of their works
  4. 4Molecular Biology7% of their works
  5. 5Cellular and Molecular Neuroscience3% of their works
  6. 6Immunology and Allergy3% of their works

Research topics

Which keywords describe Mark Cobbold's research?

The keywords of their largest research topics: CAR T Cells, Chimeric Antigen Receptor, Glycosylation, Fc Receptors, Immune Checkpoint Blockade, PD-1 and PD-L1, Therapeutic Antibodies and Foxp3.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. CAR T Cells51 topic
  2. Chimeric Antigen Receptor51 topic
  3. Glycosylation52 topics
  4. Fc Receptors41 topic
  5. Immune Checkpoint Blockade41 topic
  6. PD-1 and PD-L141 topic
  7. Therapeutic Antibodies41 topic
  8. Foxp321 topic
  9. NK Cell Recognition21 topic
  10. Natural Killer Cells21 topic
  11. TGF-ß21 topic
  12. Cancer11 topic
  13. Fragile X Syndrome11 topic
  14. Genome Engineering11 topic
  15. Glycans11 topic
  16. RNA-Guided11 topic
  17. Rett Syndrome11 topic

Where does Mark Cobbold work?

Mark Cobbold's main affiliation in the publication record is AstraZeneca (United States), United States.

How many publications and citations does Mark Cobbold have?

Science Explorer counts 22 works and 78 citations for Mark Cobbold, ranking #467,285 of 1,633,909 researchers worldwide on the composite score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.